STOP-CDI: Efficacy of Fecal Microbiota Transplantation vs Fidaxomicin vs Vancomycin in Treating and Preventing Relapse of Clostridioides Difficile Infection
- Conditions
- Clostridioides Difficile InfectionClostridioides Difficile Infection RecurrenceFecal Microbiota Transplantation (FMT)Comparative Effectiveness of CDI TreatmentsFidaxomicinVancomycin
- Interventions
- First Posted Date
- 2025-08-13
- Last Posted Date
- 2025-08-13
- Lead Sponsor
- Medical University of Warsaw
- Target Recruit Count
- 424
- Registration Number
- NCT07120490
Hybrid Closed-Loop for Perioperative Glycemic Control in T2DM With Parenteral Nutrition
- Conditions
- Type 2 Diabetes
- First Posted Date
- 2025-08-13
- Last Posted Date
- 2025-08-13
- Lead Sponsor
- Second Xiangya Hospital of Central South University
- Target Recruit Count
- 40
- Registration Number
- NCT07121504
- Locations
- 🇨🇳
Department of Metabolism and Endocrinology, Second Xiangya Hospital of Centra South University, Changsha, Hunan 410011, Changsha, Hunan, China
How Animal and Plant Protein Shakes Change the Body's Nutrient and Health Responses
- Conditions
- Cardiometabolic Health
- First Posted Date
- 2025-08-13
- Last Posted Date
- 2025-08-13
- Lead Sponsor
- University of Pittsburgh
- Target Recruit Count
- 15
- Registration Number
- NCT07121010
- Locations
- 🇺🇸
UPMC Montefiore - Clinical and Translational Research Center (CTRC), Pittsburgh, Pennsylvania, United States
PPI in Weaning Prediction
- Conditions
- Perfusion IndexWeaning of Mechanical VentilationICU
- First Posted Date
- 2025-08-13
- Last Posted Date
- 2025-08-13
- Lead Sponsor
- Gaziosmanpasa Research and Education Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT07120672
- Locations
- 🇹🇷
Gaziosmanpaşa Training and Research Hospital, İstanbul, Turkey
EOI Block for Laparoscopic Gastrostomy
- Conditions
- Gastrostomy
- First Posted Date
- 2025-08-13
- Last Posted Date
- 2025-08-13
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT07119346
- Locations
- 🇰🇷
Seoul National University Children's Hospital, Seoul, Korea, Republic of
A Novel Dialectical Behavior Therapy Brief Group Intervention for Cigarette Smoking by Patients With Cancer: An Open Clinical Trial
- Conditions
- Smoking Behavior
- First Posted Date
- 2025-08-13
- Last Posted Date
- 2025-08-13
- Lead Sponsor
- Wake Forest University Health Sciences
- Target Recruit Count
- 16
- Registration Number
- NCT07119489
- Locations
- 🇺🇸
Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina, United States
Gender Microagression Psychoeducation
- Conditions
- Mental Health
- First Posted Date
- 2025-08-13
- Last Posted Date
- 2025-08-13
- Lead Sponsor
- Yuzuncu Yıl University
- Target Recruit Count
- 80
- Registration Number
- NCT07120360
- Locations
- 🇹🇷
Van Yuzuncu Yıl University Campus /Faculty of Health Sciences/van/turkey, Van, Tusba, Turkey
🇹🇷Van Yuzuncu Yıl University, Van, Tusba, Turkey
SPARK Healthy Sleep
- Conditions
- Schizophrenia and Related DisordersSleep Disturbance
- First Posted Date
- 2025-08-13
- Last Posted Date
- 2025-08-13
- Lead Sponsor
- Indiana University
- Target Recruit Count
- 115
- Registration Number
- NCT07119268
One Cause of Heel Pain is Plantar Fasciopathy (PF). In Most Cases, a Heel Spur is Frequently Present Alongside PF. We Aim to Evaluate the Efficacy of Corticosteroid Injection and Radiofrequency Ablation, Along With Tissue Elasticity Assessed by Ultrasound, in Patients With Chronic Pain (≥6 Months).
- Conditions
- Plantar FasciopathyChronic PainCorticosteroid InjectionRadiofrequency AblationElasticity Imaging Techniques
- Interventions
- Drug: Corticosteroid InjectionProcedure: Radiofrequency thermocoagulation
- First Posted Date
- 2025-08-13
- Last Posted Date
- 2025-08-13
- Lead Sponsor
- TC Erciyes University
- Target Recruit Count
- 50
- Registration Number
- NCT07120204
- Locations
- 🇹🇷
Erciyes Üniversitesi Tıp Fakültesi, Kayseri, Talas, Turkey
A Study to Assess the Immune Response and Safety of a Vaccine Against Influenza in Adults 18 Years of Age and Older
- Conditions
- Influenza, Human
- Interventions
- Biological: Flu mRNA (Formulation A)Biological: Flu mRNA (Formulation B)Combination Product: Comparator 2Combination Product: Comparator 1Combination Product: Comparator 3
- First Posted Date
- 2025-08-13
- Last Posted Date
- 2025-08-13
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 770
- Registration Number
- NCT07121192